Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535264-25-000040
Filing Date
2025-05-09
Accepted
2025-05-09 15:47:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7042
  Complete submission text file 0001535264-25-000040.txt   8878
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Subject) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87476 | Film No.: 25930094
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

EIN.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A